PMID: 9540136Apr 16, 1998Paper

Carvedilol in the treatment of hypertension--a review of the clinical data base

Scandinavian Cardiovascular Journal. Supplement
L Hansson, A Himmelmann

Abstract

Carvedilol is a novel antihypertensive agent. It is a multiple-action neurohormonal antagonist with a beta-adrenoceptor blocking effect combined with a vasodilating action based on alpha1-adrenoceptor blockade. In addition, carvedilol exerts a number of well documented ancillary effects such as being a scavenger of free radicals. It also has an antiproliferative action on smooth muscle cells. This combination of effects opens up a number of interesting clinical perspectives. It is the purpose of this brief review to summarize some of the clinical studies that have been performed with carvedilol. Investigations in hypertensive patients will form the basis of this review, but special interest will also be devoted to other patient groups. In particular the therapeutic value of carvedilol will be discussed in patients with concomitant disorders such as atheromatosis, left ventricular hypertrophy, angina pectoris, myocardial infarction, congestive heart failure, arrhythmias, stroke, renal failure or diabetes. Finally, the usefulness of carvedilol in the treatment of elderly hypertensive patients will be reviewed. It is evident from the available scientific literature that carvedilol is an antihypertensive agent with a novel mode of ...Continue Reading

References

Jan 1, 1978·American Heart Journal·J Koch-Weser
Oct 1, 1975·British Heart Journal·F WaagsteinI Wallentin
Jul 11, 1992·Lancet·M Packer
Jan 1, 1992·European Journal of Clinical Pharmacology·B K KrämerT Risler
Oct 1, 1991·European Journal of Drug Metabolism and Pharmacokinetics·G Neugebauer, P Neubert
Aug 1, 1991·The New England Journal of Medicine·UNKNOWN SOLVD InvestigatorsJay N Cohn
Nov 1, 1986·The American Journal of Cardiology·E A RodriguesE B Raftery
Sep 1, 1987·The American Journal of Cardiology·S B FreedmanD T Kelly
Oct 1, 1988·American Journal of Hypertension·L Hansson
Jun 26, 1986·The New England Journal of Medicine·S H CroogG H Williams
Jan 1, 1987·Clinical Pharmacology and Therapeutics·L X CubedduJ R Powell
May 1, 1995·Journal of the American College of Cardiology·S L OlsenM R Bristow
Nov 17, 1994·Annals of the New York Academy of Sciences·T L YueG Z Feuerstein
Jan 1, 1993·Cardiology·L Storstein
Jan 1, 1993·Progress in Neuro-psychopharmacology & Biological Psychiatry·B Peruche, J Krieglstein
Apr 1, 1996·Journal of Internal Medicine·J Kjekshus, K Swedberg
Jun 1, 1996·Journal of Hypertension·S MacMahon
Jan 2, 1954·Journal of the American Medical Association·H P DUSTANA C CORCORAN
Feb 20, 1954·Journal of the American Medical Association·H M PERRY, H A SCHROEDER
Jan 1, 1964·American Heart Journal·E D FREIS

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

© 2022 Meta ULC. All rights reserved